Palatin Technologies expects to begin early-stage clinical trials next year for two experimental treatments designed to curb extreme hunger…
Marisa Horak, MS
Marisa holds a Master of Science in cellular and molecular pathology from the University of Pittsburgh, where she studied novel genetic drivers of ovarian cancer. Her areas of expertise include cancer biology, immunology, and genetics, and she has worked as a science writing and communications intern for the Genetics Society of America.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Marisa Horak, MS
Nearly 400 civic, business, and philanthropic leaders in South Florida gathered this week for a second annual event aimed at…
A trio of advocacy groups have come together to help families understand safety risks associated with Vykat XR (diazoxide…
People with Prader-Willi syndrome (PWS) that’s caused by a certain type of genetic mutation may experience abnormalities in how…
Long-term treatment with Vykat XR (diazoxide choline) safely provides lasting relief from the uncontrollable hunger and behavioral struggles associated…
Issues processing sensory input are a major contributing factor to irritability in people with Prader-Willi syndrome (PWS), according to…
More than half of children with Prader-Willi syndrome (PWS) show signs of spontaneous puberty, but more than three-quarters will…
Typically developing siblings of children with Prader-Willi syndrome (PWS) often report feeling misunderstood and isolated, a new review highlights.
Aardvark Therapeutics is voluntarily pausing a global clinical trial testing whether its ARD-101 treatment candidate is superior to a…
Working closely with caregivers and clinical experts, an international team of scientists has adapted an eye-tracking test to more objectively…